Probiotic found to reduce symptoms during long-term

Probiotic found to reduce eczema symptoms over long-term period Breaking News on Food, Beverage & Supplement Development - Asia PacificEU edition | US edition Headlines Formulation Nutrition Business Markets Policy Videos Audios Galleries Internet Live Events October 2012 September 2012 Previous months Regions All Asia Australia - New Zealand China India Japan Korea - Taiwan South East Asia Topics Asian tastes Supply chain Food safety Industry growth Fortification Sectors Bakery Beverages Confectionery Convenience foods and snacks Dairy Desserts Functional foods and drinks Meat Seafood Soups and sauces Supplements Traditional and staple foods Products All Products Supplier Webinars Technical Papers Product Brochures Suppliers Events Archive Related sites FoodNavigator.com FoodNavigator-USA.com NutraIngredients.com NutraIngredients-USA.com FoodNavigatorJobs Headlines Formulation Nutrition Business Markets Policy Topics Asian tastes Supply chain Food safety Industry growth Fortification Headlines > Formulation Text size Print Email
Probiotic found to reduce eczema symptoms over long-term period Post a comment By RJ Whitehead, Contact the editor, 08-Oct-2012
Related topics: Fortification, Formulation, Dairy, Australia - New Zealand, Pre- & Probiotics 2012

Clinical trials have found that a dairy culture probiotic shows significant long-term benefit for children suffering from eczema, even after they have stopped taking the supplement.


Lactobacillus rhamnosus HN001, developed from dairy cultures by Fonterra Nutrition, was shown in a previous trial to help reduce the occurrence of eczema symptoms in children by almost half when they took the probiotic up to two years of age.

Now, a follow-up study published in the journal Clinical and Experimental Allergy has shown that this reduction in symptoms continues through to four years old, even when the subjects stopped taking the probiotic half-way through the test period.

Long-term benefits

“This study adds support to the theory that the placement of beneficial bacterial cultures in the diet, through probiotics, may allow more control over infant conditions such as eczema, even after supplementation has ceased,” said Professor Julian Crane, one of the study’s authors.

He added that the findings showed that Lactobacillus rhamnosus HN001 has a long-term protective effect and could be an effective solution in reducing the risk of eczema development in children with a family history of allergy. Half of all cases of eczema are diagnosed before a child’s first birthday.

The research was carried out by the University of Otago’s Wellington Asthma Research Group, with funding provided by the New Zealand Health Research Council and Fonterra. Eczema affects around one in five children in New Zealand, and has reported childhood prevalence rates of up to 20.5 per cent in some countries.

“The long-term benefits shown by Lactobacillus rhamnosus HN001 are extremely encouraging and are particularly relevant in New Zealand, which has one of the highest incidence rates of eczema in the world,” said Dr James Dekker, a Fonterra Nutrition senior research scientist.

No side-effects

Dekker added that the results indicate that Lactobacillus rhamnosus HN001 may be able to modify the immune system early in a child’s development, to deliver long-term benefits with no discernible side-effects.

The follow-up study is part of a long-term clinical trial that started by giving probiotic bacteria or placebos to pregnant women between two and five weeks from birth. Following the birth of their infants, the mothers continued with the supplementation for up to six months, if breastfeeding, while their infants received the supplementation from birth through to two years of age.

Further research on Lactobacillus rhamnosus HN001 is due to be released early next year. This study will look into the probiotic’s effect after six years
This content is copyright protected However, if you would like to share the information in this article, you may use the headline, summary and link below:
Probiotic found to reduce eczema symptoms over long-term period

Clinical trials have found that a dairy culture probiotic shows significant long-term benefit for children suffering from eczema, even after they have stopped taking the supplement.
http://www.foodnavigator-asia.com/Formulation/Probiotic-found-to-reduce-eczema-symptoms-over-long-term-period
Keywords: New Zealand, probiotic, eczema, dairy
More news articles on this topic Pre & Probiotics across the globeStudy uncovers region's strong probiotic potentialChina approves allergy-battling probioticsProbiotic technology enters Australia and New Zealand
Get more articles like this in your mailbox:
Sign up
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions

Post a comment
Comment title * Your comment * Your name * Your email *We will not publish your email on the site
I agree to Terms and Conditions When submitted, your comment will be moderated and, once approved, will appear on the site shortly after.
Related products & Suppliers Technical Papers Stabilization of ice creams produced with a reduced level of saturated fat Product Brochures Fenlyase™ Transglutaminase, Lipase and Papain Suppliers Arla Foods Ingredients Cosucra Groupe Warcoing SA DairiConcepts, L.P. FT Technologies Fortitech Asia Pacific Sdn Bhd Galam Group Ingredia Nutritional JK Sucralose Inc. Naturex, the global botanical leader Novozymes A/S POLARIS Palsgaard Sensus. Making inulin work for you TIC gums Vitablend Most Popular News 1Aussies work extra week as a result of missing lunch2Study links heightened diabetes risk to modern oils3Probiotic found to reduce eczema symptoms over long-term period4Bumper Chinese corn harvest a ‘relief’ for beleaguered US5Icing on Vietnamese cake for Belgian confectionery joint-venture
Supplier Webinars Live Supplier Webinars 24-Oct-2012How to Create Great Tasting Products with Less Sugar!
Givaudan All supplier webinars Products Stabilization of ice creams produced with a reduced level of saturated fat
Palsgaard Strategic Nutrition for Diabetes
Fortitech Inc. Moisture caused problems in ice cream coating - a problem of the past
Palsgaard Puff pastry margarine - Focusing on functionality and fat reductions
Palsgaard Shake up coconut water
Hilmar Ingredients Today's Headlines Officials fast to slow down grain waste Quaker thrives in China with traditional medicine cereal fortification Mindanao peace could give fillip to Filipino food production Vegetable oil rise sees oilseeds literally lose ground Weekly / Daily Free Newsletter FoodNavigator.com Food & Beverage Development - Europe FoodNavigator-USA.com Food & Beverage Development - North America FoodNavigator-Asia.com Food, Beverage & Supplement Development - Asia Pacific NutraIngredients.com Supplements & Nutrition - Europe NutraIngredients-USA.com Supplements & Nutrition - North America FoodProductionDaily.com Food Processing & Packaging FoodQualityNews.com Food Safety & Quality Control DairyReporter.com Dairy Processing & Markets BeverageDaily.com Beverage Technology & Markets ConfectioneryNews.com Confectionery & Biscuit Processing BakeryAndSnacks.com Industrial Baking & Snacks GlobalMeatNews.com Global Trading and Meat Processing FoodManufacture.co.uk The Information Resource for Food and Drink Processing Other Newsletters Science & Nutrition Research Food legislation Food Finance Innovations in Food Ingredients Innovations in Food Processing and Packaging Innovations in Food Safety & Instrumentation Food Industry & Consumer Trends Food Marketing and Retailing Free subscription now!
Related Sites from our Team Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food, Beverage & Supplement Development - Asia Pacific | Food Marketing and Retailing | Food and Beverage Processing and Packaging | Food Safety & Quality Control | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Global Trading and Meat Processing | Food jobs - Europe Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceuticals: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging in North America | Cosmetics Formulation & Packaging in Europe | Cosmetics Formulation & Packaging in Asia-Pacific
About us | Site map | All sites | Recommend this Site | Advertise | Contact the Editor | Terms & Conditions | Privacy and Cookie Policy

© William Reed Business Media SAS 2012, All rights reserved.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.
[X]

View the original article here

Skin Tight: A Titillating;Eczema

Skin Tight: A Titillating;Eczema

Some people still demand standards in their advertising. A UK physician complained to a trade group that enforces an industry code that a recent ad by Genus Pharmaceuticals was “offensive and degrading due to its sexual and titillating picture,” which was used to promote a cream for treating eczema. The ad featured the back view of a young woman walking down a street as the wind lifts her short skirt to reveal red-and-white polka dot underwear.
The ad, which has since been tweaked, sported a headline that read: “Confidence to live life their way.. however that may be.” And the Prescription Medicines Code of Practice Authority, which was created by the Association of British Pharmaceutcial Industry, agreed by ruling that the “display of naked or partially naked people for the purpose of attracting attention and the use of sexual imagery for that purpose was unacceptable.”
In trying to play King Solomon, the PMCPA noted that ezema “might affect a patient’s self esteem and confidence,” a point raised by Genus in its response, and that the ad was “developed specifically to acknowledge the potential negative effects of eczema on people’s lives and demonstrate the positive impact successful treatment could have by restoring self confidence.”
The panel also acknowledged that ads to promote eczema treatments, in general, are almost certainly going to contain images of naked skin. On the other hand, the panel the ad went a bit too far, because the ad suggested that showing her panty-clad tush was not a proper example of how the Cetraben cream freed consumers to display new-found confidence in their appearance (here is the PMCPA ruling).
In its defense, cited numerous statistics about the extent to which eczema can be a debilitating condition that affects patients and insisted the ad was a “light-hearted route,” and the argued that other promotions for dermatological medicines promoted a “higher degree of nakedness than was used in the Cetraben advertisement… all of which featured people in everyday clothing none of which could be described as skimpy.”
Then, however, the drugmaker tried to dodge the accusation that a provocative image was deliberately used to sell itss product by insisting the woman in the ad was “only embarrassed that her skirt had blown up in the wind.” And thanks to the “successful treatment of her eczema she now had the confidence to wear a skirt and not cover her legs.” Genus then maintained “subjectivity” is hard to measure. As noted, the ad has now been updated to comply with the code. But what do you think?
Was The Original Ad Inappropriate?
No (57%, 88 Votes) Yes (31%, 47 Votes) The updated ad is no better (12%, 18 Votes) Total Voters: 154

View the original article here